OncoSec Medical Incorporated
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-4.47-6.97-3.62-1.13-0.96-1.27-0.51-1.64-1.58-0.85-0.10-0.96
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
6.742.202.351.081.942.170.645.001.884.78-0.552.17
Price/Cash Flow ratio
-5.77-9.33-4.36-1.70-1.19-2.14-0.54-2.09-1.71-0.91-0.12-1.19
Price/Free Cash Flow ratio
-5.66-8.83-4.03-1.56-1.19-2.13-0.54-2.09-1.68-0.90-0.12-1.19
Price/Earnings Growth ratio
0.041.15-0.110.430.020.150.000.040.030.02-0.000.15
Dividend Yield
N/AN/AN/AN/AN/AN/A0.00%N/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
-0.02%-0.34%-0.00%-0.00%-0.00%-0.00%-0.00%2.02%5.06%8.88%10.18%-0.00%
Return on Assets
-109.83%-30.49%-59.68%-82.97%-140.81%-129.39%-101.28%-141.29%-80.26%-156.22%-331.25%-129.39%
Return On Equity
-150.87%-31.55%-64.97%-95.84%-200.54%-170.72%-124.70%-304.62%-118.62%-558.63%-868.36%-170.72%
Return on Capital Employed
-149.07%-31.39%-64.96%-92.90%-181.19%-147.99%-122.08%-214.62%-100.13%-242.78%-1990.76%-147.99%
Liquidity Ratios
Current Ratio
2.9128.9511.598.483.684.895.722.356.17N/A0.894.89
Quick Ratio
2.8028.9511.598.483.684.895.722.356.172.290.504.89
Cash ratio
2.8028.5911.068.293.370.655.052.105.771.850.500.65
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/A0.000.260.130.281.61N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/A0.000.560.191.00-2.61N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.310.120.40-0.63N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.000.360.160.50-1.71N/A
Interest Coverage Ratio
-84.90-577.72N/AN/AN/AN/A-7.99K-8.48K-3.05KN/A-626.32N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/A-346.27-4.23-5.71-5.20-7.21N/A
Company Equity Multiplier
1.371.031.081.151.421.311.232.151.473.57-1.611.31
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.021.051.081.081.001.001.0011.011.001.001.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/A-346.27-4.23-5.71-5.20-7.21N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/A-346.27-22.54-20.09-15.69-18.68N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/A-0.00%N/AN/AN/AN/AN/A